GlaxoSmithKline Pharmaceuticals has informed that the board of directors of the company at its meeting held on February 19, 2013, has recommended a dividend of Rs. 50 per equity shares (Previous year : Rs. 45 per equity share).
The above information is a part of company’s filings submitted to BSE.